17-7675092-T-C
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_000546.6(TP53):c.520A>G(p.Arg174Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000546.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Li-Fraumeni syndrome Uncertain:1
In summary, this is a rare missense change with uncertain impact on protein function. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies in yeast have shown that this missense change disrupts TP53 transcriptional activity at some, but not all promoters. The clinical significance of these findings is unclear (PMID: 17606709, 21343334, 12826609). This variant has been reported in a patient with glioblastoma multiforme and breast cancer (PMID: 8308926) as well as an affected individual from a family with Li Fraumeni-like Syndrome (PMID: 17606709) and is not present in population databases. This sequence change replaces arginine with glycine at codon 174 of the TP53 protein (p.Arg174Gly). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and glycine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at